# Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

> clinical trial · VERIFIED · 2026-08-03

Status: NOT_YET_RECRUITING · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Condition: Palmoplantar Pustulosis (PPP)

- Company: Second Affiliated Hospital, School of Medicine, Zhejiang University
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07530367

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.